Transcripts for transforming growth factors in human breast cancer: clinical correlates
Authors:
- P Barrett-LeePBP Barrett-Lee
- M TraversMTM Travers
- Y LuqmaniYLY Luqmani
- Rc CoombesRCRc Coombes
Open Access
- 31 March 1990
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 61 (4) , 612-617
Abstract
The levels of mRNA for transforming growth factors (TGF alpha and beta) and the epidermal growth factor receptor (EGFR) were determined in 69 human breast carcinomas and 20 biopsies of non-neoplastic breast tissue by dot blot hybridisation analysis. TGF alpha mRNA was detected in 42% of cancers and 44% of non-neoplastic breast tissue at low levels. TGF beta mRNA was found in all breast cancers and non-neoplastic breast tissues, but the levels of TGF beta mRNA were found to be higher in breast cancers (P = 0.01). EGFR mRNA was detected in 55% of breast cancers and in all non-neoplastic breast tissue tested. The presence of EGFR mRNA was inversely related to oestrogen receptor (ER) status (P = 0.0001). Coexpression of TGF alpha and EGFR was observed in 28% of the carcinomas, and significantly more commonly in ER negative tumour s(P = 0.01). No significant relationship was found between histological grade, tumor cellularity or tumour desmoplasia and expression of either the TGFs or of EGFR mRNA. High levels of TGF beta were, however, associated with the absence of lymph node metastases at presentation (P = 0.05). Levels of TGF alpha and beta and EGFR mRNA were analysed in relationship to the relapse-free and overall survival of patients with breast cancer, but none was found to predict siginificantly the outcome in these patients. Longer clinical follow-up and larger numbers of patients are required to determine whether TGFs will prove a useful marker for prognosis in breast cancer patients.Keywords
This publication has 25 references indexed in Scilit:
- Differential expression of platelet‐derived growth factor and transforming growth factor genes in small‐ and non‐small‐cell human lung carcinoma linesInternational Journal of Cancer, 1988
- CHARACTERIZATION OF ESTROGEN-RECEPTOR MESSENGER-RNA IN HUMAN-BREAST CANCER1987
- Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.Proceedings of the National Academy of Sciences, 1987
- FREQUENT EXPRESSION OF GROWTH-FACTORS FOR MESENCHYMAL CELLS IN HUMAN MAMMARY-CARCINOMA CELL-LINES1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.Journal of Clinical Oncology, 1986
- The biology of platelet-derived growth factorCell, 1986
- Role of epidermal growth factor in carcinogenesis.1986
- Epidermal growth factor receptors on human breast cancersBritish Journal of Surgery, 1985
- Autocrine growth factors and cancerNature, 1985